Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.
Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
AdvanCell develops targeted alpha radiopharmaceutical therapies for cancer and supports their development and manufacturing.
Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.
Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.
Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device .
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.
Ria Health is an online platform providing telehealth services for alcohol use disorder.
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington's disease.
CSA Medical is a provider of innovative spray cryotherapy medical device solutions.
U.S. Renal Care is a healthcare service provider that focuses on serving patients in dialysis facilities.
Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
SV Health Investors has invested in 76 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
SV Health Investors's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 16 different industry categories.
Among tracked funding rounds, AdvanCell received $315.0M in a Series D round. SV Health Investors's total known invested capital is $3.1B.
SV Health Investors's average investment size is $48.4M across its portfolio of 76 companies.
Recent SV Health Investors portfolio additions include Sitryx Therapeutics, KalVista Pharmaceuticals, Spectrawave, Alchemab Therapeutics, AdvanCell. These companies were founded in 2020 or later.